RxDoctor Payments Data

Timothy Oskin, MD

Vascular Surgery · Easton, PANPI 1003857491

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $13,279 of the $18,037 with a category attached, or 73.6%. 39 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 30.6% of the total. Reporting peaked in 2024 at $7,396 and has fallen 50.5% since, to $3,660 in 2025.

$18,037in general payments, 2019–2025

Across 220 payments — averaging $81.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$6K
  • Penumbra, Inc.$3K
  • Silk Road Medical, Inc.$2K
  • Endologix LLC$1K
  • Boston Scientific$1K
  • Medtronic$828
  • plus $5K from 33 others
$25,597in research payments, 2019–2025

Across 7 payments — averaging $3656.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Silk Road Medical, Inc.$26K

What the payments were for

  • Consulting fees$1,3107%
  • Travel & lodging$3,44819%
  • Food & beverage$13,27974%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,037 in reported general payments places this provider in the 85th percentile of 236 vascular surgery providers in Pennsylvania.

See all vascular surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$106,556
Medicare patients
166
Services billed
402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Easton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →